<DOC>
	<DOCNO>NCT00708786</DOCNO>
	<brief_summary>The purpose study report incidence ventricular arrhythmia correlate SAS focus interest diagnose Sleep-disorders breathing ICD patient . This diagnosis assess ambulatory nasal pressure record portable multi-channel recorder associate complete SAS relate symptom questionnaire.This clinical trial first step gather information suspect sleep relation ventricular arrhythmias Sleep breathing disorder , order improve management treatment arrhythmia next generation defibrillator integrate minute ventilation sensor able monitor breathing .</brief_summary>
	<brief_title>Ventricular Arrhythmias Incidence According Sleep Apnea Syndrome Implantable Cardioverter-Defibrillator ( ICD ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Patients risk sudden death due ventricular arrhythmia satisfy least one follow criterion eligible enrolment : Class I indications ICD Survival least one episode cardiac arrest due VT VF due transient reversible cause , presume due VF electrophysiological testing preclude medical condition ; Spontaneous sustain ventricular tachycardia , Syncope undetermined origin clinically relevant haemodynamically significant sustain VT VF induce electrophysiological study drug therapy ineffective , tolerate preferred , Class IIa Indication ICD Nonsustained VT coronary disease , prior myocardial infarction , leave ventricular dysfunction ( ≤ 40 % ) inducible VF sustain VT electrophysiological study . With prior myocardial infarction LVEF le 30 % ( without prior lifethreatening arrhythmia sustain VT ) . Patients candidate cardiac resynchronization therapy ( CRT ) need functional Class III IV NYHA classification . Patients include grant informed consent participate study , precede delivery appropriate information VT/VF associate drug toxicity , electrolyte imbalance , hypoxia , electrocution reversible cause ; VT/VF occur acute phase infarction ( &lt; 1 week ) unstable ischemic phase ; Incessant VT/VF ; Implanted pacemaker go explanted otherwise disable ; Inability refusal provide informed consent Tricuspid valvular disease tricuspid mechanical heart valve ( lead contraindication ) ; Unable understand purpose plan study ; Geographically unstable available followup define investigational plan ; Reduced life expectancy ( ≤ 1 year ) cardiovascular reason ; Patient participate another clinical study ; Patient minor age ( &lt; 18 year ) ; Pregnancy ( Women childbearing potential require negative pregnancy test within seven day prior enrollment ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>